沃脈德資本 OrbiMed www.orbimed.com 
全球最大的專注于生物醫(yī)療領(lǐng)域的投資公司。沃脈德資本專注于醫(yī)療和生命科學(xué)領(lǐng)域的投資公司，目前管理的資產(chǎn)規(guī)模逾50億美元。自1993年開始其私募股權(quán)投資業(yè)務(wù)以來，沃脈德資本已經(jīng)成功投資了100多家私營(yíng)企業(yè)。沃脈德資本的投資團(tuán)隊(duì)由30多位經(jīng)驗(yàn)豐富的專業(yè)人士組成，其專業(yè)背景包括生命科學(xué)、醫(yī)學(xué)、醫(yī)療行業(yè)、金融和法律。在2008年，沃脈德資本募集了第一個(gè)泛亞洲專注于醫(yī)療和生命科學(xué)領(lǐng)域的風(fēng)險(xiǎn)投資基金，管理資產(chǎn)近2億美元。沃脈德資本在紐約、上海、孟買和舊金山均設(shè)有辦事機(jī)構(gòu)。

United States
601 Lexington Avenue (at 53rd Street)
54th Floor
New York, NY 10022-4629
+1 (212) 739-6400
455 Mission Bay Boulevard South
Suite 555
San Francisco, CA 94158
+1 (415) 294-8740
India
Suite G 20A, Grand Hyatt Plaza
Santacruz (East)
Mumbai, 400055 India
+(91) 22-3066-2000
China
Unit 4301, Bund Center, No. 222 East Yan An Road
Shanghai 200002, P.R. China
+(86) 21-6335-1700
Israel
89 Medinat HaYehudim st.
Build E, 11th Floor
Herzliya 46766
+972 73 2822600

OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, with approximately $7 billion in assets under management. OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinational companies. OrbiMed’s team of over 60 professionals manages a series of private equity funds, public equity funds, royalty and debt funds, and other investment vehicles.